New target for drug intervention in Alzheimer's disease identified

Scientists at UAB have identified an enzyme in the brain, LIMK1, that may be an intriguing target for interventions against Alzheimer’s disease and other dementias. LIMK1 appears to play a role in the degradation of dendritic spines.
Source: EurekaAlert, https://www.eurekalert.org